Treatment recommended |
1. Zone I ROP at any stage with plus disease |
2. Zone I ROP stage 3 without plus disease |
3. Zone II stage 2 or 3 with plus disease |
Follow-up examination interval |
1 week or less |
Zone I: immature retina, stage 1 or 2 ROP |
Zone II: stage 3 ROP |
Presence or suspected presence of APROP |
1–2 weeks |
Zone I: unequivocally regressing ROP |
Posterior zone II: immature retina |
Zone II: stage 2 ROP |
2 weeks |
Zone II: immature retina, stage 1 ROP, unequivocally regressing ROP |
2–3 weeks |
Zone II: stage 1 ROP |
Zone III: stage 1 or 2 ROP, regressing ROP |
Screening is discontinued if the following are present |
1. Zone III vascularization without previous zone I or II disease |
2. 360 degrees of full retinal vascularization |
3. Postmenstrual age of 50 weeks without prethreshold disease |
4. Regression of ROP in zone III without abnormal vascular tissue that can reactivate in zones II or III |